Cargando…
Correction: MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells
Autores principales: | Liu, Xiaoping, Lei, Qianqian, Yu, Zhibin, Xu, Gang, Tang, Hailin, Wang, Wei, Wang, Zeyou, Li, Guiyuan, Wu, Minghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733623/ https://www.ncbi.nlm.nih.gov/pubmed/33346242 http://dx.doi.org/10.18632/oncotarget.27716 |
Ejemplares similares
-
MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells
por: Liu, Xiaoping, et al.
Publicado: (2015) -
CPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in glioma
por: Xiaoping, L, et al.
Publicado: (2013) -
miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells
por: Lei, Qianqian, et al.
Publicado: (2015) -
Disturbing miR-182 and -381 Inhibits BRD7 Transcription and Glioma Growth by Directly Targeting LRRC4
por: Tang, Hailin, et al.
Publicado: (2014) -
Correction to: miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma
por: Sun, Yingnan, et al.
Publicado: (2021)